Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MD.

Rebecca Sheets, Johannes Loewer, Gopa Raychaudhuri, John Petricciani

National Institutes of Health, National Institute of Allergy & Infectious Diseases, Bethesda, MD, USA. RSheets@niaid.nih.gov

Biologicals : journal of the International Association of Biological Standardization 2012 Mar

filter terms:

In May 2011, the International Alliance for Biological Standardization, with the cooperation of WHO, FDA, and NIAID, organized a conference on adventitious agents that might be found in biological products using new technology (http://www.iabs.org/index.php/past-conference-reports/116-baltimore-2011-slides). The implications of such findings on risk assessment also were considered. Topics that were addressed included: a) current routine testing--what are we doing now?; b) recent advances in testing--what tests are being explored/applied?; c) examples of finding agents with "new" techniques; and d) risk assessment, including recent WHO activities. A draft algorithm for risk assessment was discussed in terms of its applicability to a variety of potential new agents and the possibilities for improving it. Copyright Â© 2012. Published by Elsevier Ltd.. All rights reserved.

Citation

Rebecca Sheets, Johannes Loewer, Gopa Raychaudhuri, John Petricciani. Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MD. Biologicals : journal of the International Association of Biological Standardization. 2012 Mar;40(2):162-7